| Cat. No. |
Product Name |
Information |
| PC-60146 |
APD-371
CB2 agonist
|
APD-371 (APD371, Olorinab) is a potent, selective and orally available CB2 agonist with EC50 of 6.2 nM. |
| PC-60086 |
AM-6538
|
AM-6538 (AM6538) is a potent, selective cannabinoid receptor CB1 antagonist with Ki of 5.1 nM.. |
| PC-45531 |
JD-5037
CB1 antagonist
|
JD-5037 is a potent, selective and peripherally restricted cannabinoid-1 (CB1) receptor blocker with IC50 of 2 nM, does not inhibit CB2 receptor (IC50>1000 nM). |
| PC-42171 |
Bay 59-3074
CB1/CB2 agonist
|
Bay 59-3074 is a potent, selective cannabinoid CB1/CB2 receptor partial agonist with Ki of 48.3, and 45.5 nM for human CB1 and human CB2 receptors, respectively. |
| PC-42063 |
Taranabant
CB1 inverse agonist
|
Taranabant (MK-0364) is a potent, selective and orally active cannabinoid-1 receptor (CB1R) inverse agonist with IC50 of 2.8 nM, Ki of 0.13 nM. |
| PC-42723 |
Otenabant
CB1 antagonist
|
Otenabant (CP-945598) is a potent, and selective CB1 receptor antagonist with Ki of 0.7 nM/0.12 nM in binding and functional assays respectively. |
| PC-22234 |
HU-308
CB2 agonist
|
HU-308 is a potent, selective cannabinoid CB2 receptor agonist with Ki of 22.7 nM in competition binding assay, does not bind to CB1 receptor. |
| PC-22233 |
HU-910
CB2 agonist
|
HU-910 is a potent, selective cannabinoid CB2 receptor agonist with Ki of 6 nM in competition binding assay, IC50 of 162 nM in cAMP assay. |
| PC-22211 |
SCH225336
CB2 inverse agonist
|
SCH225336 (SCH336) is a potent, selective cannabinoid receptor CB2 inverse agonist with Ki of 0.4 nM, >2000-fold selective over CB1 receptor. |
| PC-22188 |
SR141716
CB1 antagonist
|
Rimonabant (SR141716) is a highly potent, brain penetrated and selective central cannabinoid receptor (CB1) antagonist with Ki of 1.8 nM, no affinity for peripheral cannabinoid receptor. |
| PC-22167 |
AM10257
CB2 antagonist
|
AM10257 is a potent, selective cannabinoid receptor 2 (CB2) antagonist with IC50 of 47 nM. |
| PC-22115 |
SMM-189
CB2 inverse agonist
|
SMM-189 is a selective cannabinoid receptor 2 (CB2) inverse agonist with Ki of 121.3 nM, 40-fold selective over CB1 receptor. |
